Literature DB >> 26464189

Ficolin Gene Polymorphisms in Systemic Lupus Erythematosus and Rheumatoid Arthritis.

Catarina Addobbati1,2, Jaqueline de Azevêdo Silva2, Nathália A C Tavares2, Odirlei Monticielo3, Ricardo M Xavier3, João Carlos T Brenol3, Sergio Crovella1,2, José Artur B Chies4, Paula Sandrin-Garcia1,2.   

Abstract

Systemic lupus erythemathosus (SLE) and rheumatoid arthritis (RA) are complex autoimmune diseases characterized by an immune balance breakdown and by chronic inflammation. Several findings link SLE and RA development with the complement system and ficolin components have emerged as candidates for disease development. Since genetic association studies with ficolin genes in SLE and RA have not yet been conducted in a Brazilian population, the aim of this study was to determine whether polymorphisms of ficolin-1(FCN1) and ficolin-2 (FCN2) genes are associated with SLE and RA susceptibility as well as disease manifestation. Two SNPs within FCN1 (rs2989727 and 1071583) and three in FCN2 (rs17514136, rs3124954, and rs7851696) were studied in 208 SLE and184 RA patients as well as 264 healthy individuals in a Southeast Brazilian population. For SLE patients, the FCN2 rs17514136 SNP was associated with a more severe disease (SLICC) (p = 0.0067). Furthermore, an association between the occurrence of nephritis and the T/T genotype for FCN2 rs3124954 SNP (p = 0.047, OR = 3.17, 95%CI = 1.34-7.5) was observed. No association was observed between the studied polymorphisms and RA development. Thus, our data support involvement of the FCN2 gene in the SLE phenotype.
© 2015 John Wiley & Sons Ltd/University College London.

Entities:  

Keywords:  Autoimmunity; complement system; genetic variants; rheumatology

Mesh:

Substances:

Year:  2015        PMID: 26464189     DOI: 10.1111/ahg.12129

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  6 in total

1.  Lectin pathway factors in patients suffering from juvenile idiopathic arthritis.

Authors:  Katarzyna Kasperkiewicz; Łukasz Eppa; Anna S Świerzko; Marcin A Bartłomiejczyk; Zbigniew M Żuber; Katarzyna Siniewicz-Luzeńczyk; Elżbieta Mężyk; Misao Matsushita; Leokadia Bąk-Romaniszyn; Krzysztof Zeman; Mikael Skurnik; Maciej Cedzyński
Journal:  Immunol Cell Biol       Date:  2017-04-13       Impact factor: 5.126

2.  Plasma ficolin levels and risk of nephritis in Danish patients with systemic lupus erythematosus.

Authors:  Nima Tanha; Katrine Pilely; Mikkel Faurschou; Peter Garred; Søren Jacobsen
Journal:  Clin Rheumatol       Date:  2016-12-15       Impact factor: 2.980

3.  Sickening or Healing the Heart? The Association of Ficolin-1 and Rheumatic Fever.

Authors:  Sandra Jeremias Catarino; Fabiana Antunes Andrade; Angelica Beate Winter Boldt; Luiza Guilherme; Iara Jose Messias-Reason
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

4.  The clinical value of ficolin-3 gene polymorphism in rheumatic heart disease. An Egyptian adolescents study.

Authors:  Maher H Gomaa; Emad Gamil Khidr; Ahmed Elshafei; Hala S Hamza; Aya M Fattouh; Ahmed A El-Husseiny; Ahmed Aglan; Mahmoud Gomaa Eldeib
Journal:  BMC Res Notes       Date:  2021-01-26

5.  Association of ficolin-1 and ficolin-3 gene variation and pulmonary tuberculosis susceptibility in a Chinese population.

Authors:  Ye Li; En-Qing You; Wen-Hong Lin; Xiao-Ning Liu; De-Pei Shen; Xin-Li Zhang; Dong-Chun Ma; Hong-Miao Li
Journal:  J Clin Lab Anal       Date:  2021-02-16       Impact factor: 2.352

6.  Pattern Recognition Molecules of Lectin Complement Pathway in Ischemic Stroke.

Authors:  Gohar Tsakanova; Ani Stepanyan; Rudi Steffensen; Armine Soghoyan; Jens Christian Jensenius; Arsen Arakelyan
Journal:  Pharmgenomics Pers Med       Date:  2021-10-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.